The Endocrine Society has signed on as a partner to JDRF’s Coverage2Control campaign, calling on insurance companies to provide better health coverage for the 1.25 million Americans living with type 1 diabetes. Coverage2Control, launched in May, has the support of more than 52,000 people who have signed JDRF’s petition urging insurance companies to provide coverage...
Join Your Colleagues & Advocate for Your Endocrine Research!
As the U.S. government approaches the new fiscal year (FY), beginning October 1, ongoing congressional battles over the budget are causing a great deal of uncertainty regarding the funding outlook for the National Institutes of Health (NIH) and other federal agencies and programs in FY 2018. In August, Congress left for their summer recess without...
Endocrine Society Joins Effort to Get September Named PCOS Month
The Endocrine Society and its patient education arm, the Hormone Health Network, have joined with other associations, members of Congress, and PCOS Challenge: The National Polycystic Ovary Syndrome Association to designate September as Polycistic Ovary Syndrome Month. PCOS Challenge worked with Congressman David Scott (D-GA-13) and 20 other leaders in the U.S. House of Representatives...
NIH Funding Outlook Uncertain Amid Big-Picture Budget Battles
The Endocrine Society has been encouraged by the significant increases in funding for the National Institutes of Health (NIH) in fiscal years (FY) 2016 and 2017. However, further steady and sustainable increases in funding are needed to undo damage cause by years of flat funding prior to 2016. At the time this article was written,...
On July 7, Health and Human Services Secretary Tom Price announced that Brenda Fitzgerald had been selected as director of the Centers for Disease Control and Prevention (CDC). Fitzgerald is an obstetrician-gynecologist who served as the commissioner of the Georgia Department of Public Health. In that capacity, Fitzgerald served on an advisory council on childhood...Senate Considers Health Reform Legislation; Timing Uncertain
The U.S. Senate was working hard to develop its version of a health reform measure, but timetable expectations continue to shift. The U.S. House of Representatives passed its version of a health reform bill in May; the Senate leadership had hoped to pass an alternative healthcare coverage measure by the end of June. Senate Republicans...
During the past three years, the Endocrine Society has worked to expand its global advocacy concerning endocrine-disrupting chemicals (EDCs). The Society has become a recognized leader in advocating for policies and regulatory strategies for EDCs that reflect the latest endocrine science and incorporate principles of endocrinology. EDCs are chemicals that interfere with the normal function...
NIH Rolls Back Proposal to Limit Grant Support to Individual Investigators
As reported previously in the May issue of Endocrine News, the National Institutes of Health (NIH) proposed to implement a new policy to place a cap on total research support that may be received by an individual investigator. The cap, based on a metric called the Grant Support Index (GSI), would be equivalent to 3...
Endocrinology Advocacy
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
